Reporter covering health and medicine Education: Syracuse University, BS in journalism Laurie McGinley covers health and medicine for The Washington Post. She focuses on the Food and Drug Administration as well as cancer research and treatment. She was previously The Post's health, science and environment editor. Honors & Awards:
Part of Wall Street Journal team that won the 1997 Pulitzer Prize for national reporting on AIDS
Professional Affiliations: Association of Health Care Journalists
Three of the authors of a study that found the antimalarial drug hydroxychloroquine was dangerous for hospitalized covid-19 patients retracted it Thursday, saying they could “no longer vouch for the veracity of the primary data sources.”
The first tranche of 607,000 vials of remdesivir were delivered in some cases to the wrong hospitals, to hospitals with no ICUs and therefore no eligible patients, and to facilities with no available refrigeration, according to nine current and former senior administration officials.
Trump administration said it has awarded a $354 million contract to a Virginia start-up that will manufacture a variety of generic drugs and their ingredients — including medicines used to treat covid-19 — at advanced manufacturing facilities in the United States.